Key result
Novel PCSK9 missense mutations link directly to familial hypercholesterolemia.
Observational (n=51)
Answers are grounded in this paper and cite their sources.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is at a locus for autosomal dominant hypercholesterolemia, and recent data indicate that the PCSK9 gene is involved in cholesterol biosynthesis. Mutations within this gene have previously been found to segregate with hypercholesterolemia. In this study, DNA sequencing of the 12 exons of the PCSK9 gene has been performed in 51 Norwegian subjects with a clinical diagnosis of familial hypercholesterolemia where mutations in the low-density lipoprotein receptor gene and mutation R3500Q in the apolipoprotein B-100 gene had been excluded. Two novel missense mutations were detected in the catalytic subdomain of the PCSK9 gene. Two patients were heterozygotes for D374Y, and one patient was a double heterozygote for D374Y and N157K. D374Y segregated with hypercholesterolemia in the two former families where family members were available for study. Our findings support the notion that mutations in the PCSK9 gene cause autosomal dominant hypercholesterolemia.
No takes yet. Share an insight, caveat, or question.
TP Leren (2004) conducted an observational in familial hypercholesterolemia (n=51). PCSK9 gene mutations was evaluated on Detection of mutations in the PCSK9 gene. PCSK9 gene sequencing in 51 subjects with familial hypercholesterolemia identified two novel missense mutations (D374Y and N157K) that segregated with the disease.
Synapse has enriched 10 related papers. Consider them for comparative context: